PharmaBoardroom

ICER Strikes Again: Scandal Time?

The US drug-price watchdog, The Institute for Clinical & Economic Review (ICER) recently issued a “Report on Unsupported Price Increases“,…

Janet Hoogstraate – Chair of the Management Board, Valneva…

Infectious diseases kill over 17 million people each year, according to the WHO, which is why vaccine-specialist Valneva is continuing to grow and…

Bridging the Innovation Gap with AI

Professor Jackie Hunter looks at why the pharmaceutical industry has been so slow to adopt artificial intelligence-based technologies and makes a…

Four Top US Investments in UAE Healthcare

The UAE is putting a greater emphasis on healthcare than ever before as part of its ‘Vision 2021’ model. With the aim of being "flexible in…

The Sea Turtles: China’s Top Pharma Talent Comes Home

The meteoric growth of the pharmaceutical industry in China in recent years has seen a host of top Chinese talent return home from studying and…

US FDA CBD Approvals Set to Soar

Sophia Ononye outlines the history of cannabis as a medicine in the US and, following the first FDA approval of a cannabis-derived drug product in…

Chang Yi Wang – Chairperson and Chief Scientific Officer…

United Biomedical, Inc. (UBI) is dedicated to the discovery, development, and commercialization of immunotherapies & vaccines for chronic and…

James Chiu – General Manager, Fresenius Kabi Taiwan

James Chiu, GM of Fresenius Kabi Taiwan, discusses the affiliate’s portfolio offering of parenteral and enteral nutrition in Taiwan as well as its…

AI in Healthcare M&A: On the Rise

David H. Crean, managing director for Objective Capital Partners, highlights the latest trends in mergers and acquisition (M&A) activities…

AI in APAC Healthcare: Building the Foundations

Vishal Doshi looks at how AI is already revolutionising healthcare in Asia-Pacific and the work still to be done on the foundational elements –…

New York: A Biotech Hub to Rival Boston & California?

Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up. Thanks in large part to its strong…

The Three Top Political Issues for Big Pharma

Eurasia Group’s Aditya Bhattacharji and Sarah Hassan identify and unpack the top three political and policy issues that multinational pharmaceutical…

Tagged with US